Cambridge Investment Research Advisors’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,378
| Closed | -$14K | – | 3522 |
|
|
2024
Q4 | $14K | Hold |
2,378
| – | – | ﹤0.01% | 3436 |
|
|
2024
Q3 | $23K | Hold |
2,378
| – | – | ﹤0.01% | 3359 |
|
|
2024
Q2 | $49K | Hold |
2,378
| – | – | ﹤0.01% | 3218 |
|
|
2024
Q1 | $107K | Hold |
2,378
| – | – | ﹤0.01% | 3145 |
|
|
2023
Q4 | $112K | Buy |
+2,378
| New | +$112K | ﹤0.01% | 3018 |
|
|
2021
Q4 | – | Sell |
-459
| Closed | -$223K | – | 3180 |
|
|
2021
Q3 | $223K | Sell |
459
-208
| -31% | -$101K | ﹤0.01% | 2718 |
|
|
2021
Q2 | $310K | Buy |
667
+163
| +32% | +$75.8K | ﹤0.01% | 2446 |
|
|
2021
Q1 | $348K | Buy |
504
+148
| +42% | +$102K | ﹤0.01% | 2180 |
|
|
2020
Q4 | $263K | Sell |
356
-25
| -7% | -$18.5K | ﹤0.01% | 2254 |
|
|
2020
Q3 | $264K | Buy |
+381
| New | +$264K | ﹤0.01% | 2034 |
|